NA Proactive news snapshot: NexTech AR, Orgenesis, Melkior Resources, Steppe Gold, Auryn Resources ...

NA Proactive news snapshot: NexTech AR, Orgenesis, Melkior Resources, Steppe Gold, Auryn Resources ...

Proactive Investors

Published

NexTech AR Solutions Corp (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) said it has acquired the AirShow app, artificial intelligence (AI) code and a team of four experienced augmented reality (AR) developers from TRICK 3D in a deal that is due to close on October 1. The AirShow app allows users to buy tickets to watch performances from real music artists and turns performers into ‘live’ holograms that they can interact with, providing what the company said is “an immersive and engaging experience all music fans will love”. The app is available to download on iTunes and the Google Play Store. Orgenesis Inc (NASDAQ:ORGS) announced Tuesday that it will acquire Koligo Therapeutics Inc, a regenerative medicine company, before year-end. According to a statement, Koligo is a leader in developing personalized cell therapies utilizing the patient’s own (autologous) cells. Koligo has successfully launched its first commercial product, KYSLECEL, and plans to commence a Phase 2 trial of KT-PC-301 for COVID-19-related acute respiratory distress syndrome (ARDS). Koligo’s development stage technology utilizes 3D bioprinting and vascularization with autologous cells (3D-V technology) to create biodegradable and shelf-stable three-dimensional cell and tissue implants. The 3D-V technology is being developed for diabetes and pancreatitis, with longer-term applications for neural, liver, and other cell/tissue transplants. Following the closing of the transaction, Orgenesis plans to accelerate the commercial scaleup of KYSLECEL throughout the US and in international markets as well. Melkior Resources Inc (CVE:MKR), the junior metals explorer, announced a landmark deal with mining major Kirkland Lake Gold Ltd (TSE:KL), which will see the latter advance its Carscallen project in Ontario as operator, and have the right to earn up to a 75% stake. "We are extremely excited to close this landmark equity investment and option agreement with one of the world's most respected gold mining companies," said CEO at Melkior, Jonathon Deluce in a statement. "With Kirkland Lake Gold committing $3 million with the potential of $110 million in work commitments over the next five to ten years to attain a 75% interest in the Carscallen project, our shareholders now have the upside of discovery with limited further share dilution to advance the project." Steppe Gold Ltd (TSE:STGO) revealed that it has secured an initial tranche of debt funding for its project to expand production at its flagship ATO gold mine via fresh rock ores to 150,000 ounces equivalent a year. The financing, obtained through Mongolia's Gold-2 program, is for the initial amount of around US$10.5 million, and was facilitated through the Central Bank of Mongolia and provided by the Trade and Development Bank of Mongolia (TDB). "With the expansion of the ATO Gold Mine now well underway, we are keen to ensure our financing arrangements allow us to move quickly to construction and then to production," said Steppe Gold's CEO Bataa Tumur-Ochir in a statement. Auryn Resources Inc (TSE:AUG) (NYSEAMERICAN:AUG) on Tuesday revealed 12 drill targets on the company’s Committee Bay gold project in Nunavut, that set the stage for a 2021 drill program. The targets, which are within known gold-bearing systems, were refined, thanks to a new understanding of high-grade systems across the gold belt based on geophysical conductivity data that Auryn had collected over the years, according to the company. A planned summer 2021 drill program will test both target extensions at the Three Bluffs deposit as well as several regional greenfield targets, the Vancouver-based firm told shareholders. Lexaria Bioscience Corp (OTCQB:LXRP) (CSE:LXX) announced Tuesday that its ethics board has approved a pilot human study evaluating the ability of its DehydraTECH drug delivery platform to boost the effectiveness of antiviral drugs being studied against coronavirus strains. Now that the company has the blessing of its ethics board, it will begin the process of filing for approval from federal regulators. Lexaria also announced the launch of a separate rodent antiviral study to evaluate potential pharmacokinetic benefits of DehydraTECH in the delivery of two classes of antiviral drugs being investigated as treatments for COVID-19. Dosing of the rodents has already begun and results are expected in December, the company said. Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) announced that the company has initiated a formal process to “explore and evaluate” strategic alternatives “to enhance shareholder value.” In a statement, the Laval, Quebec-based biopharmaceutical innovator said it has engaged Oppenheimer & Company Inc as its financial advisor to assist in the process. “There can be no assurance of a successful outcome from these efforts, or of the form or timing of any such outcome,” the company said in a brief statement. Meanwhile, Acasti Pharma emphasized that along with its clinical advisors, it plans to “complete the full data analyses” as contemplated in the Statistical Analysis Plan for TRILOGY 2, including the secondary and exploratory endpoints, and “the pooling of the data from TRILOGY 1 and 2.” The Valens Company Inc (CVE:VLNS) (OTCQX:VLNCF), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, announced Tuesday the launch of a new higher potency cannabis-infused beverage Summit 10, under a white label agreement with A1 Cannabis Company. Summit 10, a lemonade iced tea containing 10 milligrams (mg) of THC, is the third addition to Valens’ and A1's line of cannabis-infused beverages, according to a statement. Available in a 355 milliliter (ml) bottle, Summit 10 differentiates from the previously released 2.5mg THC-infused Summit beverage, with a flavour profile of citrus and black tea and a higher potency level, Valens said. Benchmark Metals Inc (CVE:BNCH) (OTCQB:BNCHF) told investors it had hired an experienced mining executive as vice-president of engineering, along with the company JDS Energy & Mining Inc (JDS) as lead consultant, to advance its flagship Lawyers project in British Columbia toward a preliminary economic assessment (PEA) earmarked for the second quarter this year. Benchmark's chief executive John Williamson said the mine developer now had a "heavy-weight" team with builder mentality to rapidly advance the asset with a vision beyond the PEA. Metalla Royalty & Streaming Ltd (NYSE American: MTA-CVE: TSXV: MTA) said it has completed its previously announced acquisition of a 2.5% net smelter return royalty interest on the northern and southern portions of Kirkland Lake Gold Ltd’s Fosterville mine in Victoria, Australia, for A$6 million consisting of A$2 million in cash and 467,730 Metalla shares. Tocvan Ventures Corp (CSE:TOC) said drill hole permitting had begun for its Pilar gold-silver project in Sonora, Mexico, ahead of a maiden drill program at the property, which the company believes could host a world-class discovery. In a statement on Tuesday, which outlined the findings of geophysical, geochemical and structural specialists who were brought together to perform analysis at the site, the firm also revealed it was currently getting quotes from drill companies. One significant conclusion from the analysis of specialists, is the interpretation of a sub-vertical 100 metre (m) diameter pipe that "may represent a breccia feeder pipe related to epithermal mineralization," noted Tocvan. Such breccia pipes can hold bonanza grades (more than 1 ounce per ton [opt] of gold and silver).    

Full Article